About Clyde Biosciences
Clyde Biosciences is a company based in Holytown (United Kingdom) founded in 2012 by Godfrey Smith and Francis Burton.. Clyde Biosciences has raised $3.5 million across 2 funding rounds from investors including University of Glasgow, Scottish Enterprise and European Union. The company has 6 employees as of July 31, 2022. Clyde Biosciences offers products and services including CellOPTIQ Platform, CiPA Assay, and Heart Failure Assay. Clyde Biosciences operates in a competitive market with competitors including Anabios, Metrion Biosciences, Quiver Bioscience, Zen-Bio and Rules-Based Medicine, among others.
- Headquarter Holytown, United Kingdom
- Employees 6 as on 31 Jul, 2022
- Founders Godfrey Smith, Francis Burton
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Clyde Biosciences Limited
- Date of Incorporation 07 Mar, 2012
- Jurisdiction MOTHERWELL, LANARKSHIRE, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.5 M (USD)
in 2 rounds
-
Latest Funding Round
$300.9 K (USD), Grant
Sep 01, 2015
-
Investors
University of Glasgow
& 3 more
-
Employee Count
6
as on Jul 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clyde Biosciences
Clyde Biosciences offers a comprehensive portfolio of products and services, including CellOPTIQ Platform, CiPA Assay, and Heart Failure Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Measures voltage, calcium, and contractility in cardiomyocytes for drug safety.
Predicts pro-arrhythmic risks using human stem cell-derived cardiomyocytes.
Evaluates drug effects on cardiac function for heart failure studies.
Funding Insights of Clyde Biosciences
Clyde Biosciences has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $300.9 thousand completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $300,904
-
First Round
First Round
(20 Mar 2015)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Grant - Clyde Biosciences | Valuation |
investors |
|
| Mar, 2015 | Amount | Series A - Clyde Biosciences | Valuation | Epidarex Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clyde Biosciences
Clyde Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Glasgow, Scottish Enterprise and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clyde Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Clyde Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clyde Biosciences Comparisons
Competitors of Clyde Biosciences
Clyde Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Metrion Biosciences, Quiver Bioscience, Zen-Bio and Rules-Based Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| domain | founded_year | HQ Location |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| domain | founded_year | HQ Location |
Developer of transformational medicines for neurological disorders
|
|
| domain | founded_year | HQ Location |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
|
| domain | founded_year | HQ Location |
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Clyde Biosciences
Frequently Asked Questions about Clyde Biosciences
When was Clyde Biosciences founded?
Clyde Biosciences was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is Clyde Biosciences located?
Clyde Biosciences is headquartered in Holytown, United Kingdom. It is registered at Holytown, North Lanarkshire, United Kingdom.
Is Clyde Biosciences a funded company?
Clyde Biosciences is a funded company, having raised a total of $3.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.5M, raised on Mar 20, 2015.
How many employees does Clyde Biosciences have?
As of Jul 31, 2022, the latest employee count at Clyde Biosciences is 6.
What does Clyde Biosciences do?
Clyde Biosciences is a boutique Contract Research Organisation for cardiac safety testing. Clydes CellOPTIQ platform delivers high-resolution functional output from a range of cardiac cell types including iPS-derived heart cells. High bandwidth membrane voltage signals from CellOPTIQ provides insights into electrophysiological effects of drugs. Rapid data capture and analysis is made possible by their bespoke software which allows accelerated assay throughput in a 96 well format. Their services include Calcium, Voltage, Contractility, In Silico Modelling, CiPA Studies, Bespoke RD.
Who are the top competitors of Clyde Biosciences?
Clyde Biosciences's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
What products or services does Clyde Biosciences offer?
Clyde Biosciences offers CellOPTIQ Platform, CiPA Assay, and Heart Failure Assay.
Who are Clyde Biosciences's investors?
Clyde Biosciences has 4 investors. Key investors include University of Glasgow, Scottish Enterprise, European Union, and Epidarex Capital.
What is Clyde Biosciences's valuation?
The valuation of Clyde Biosciences is $5.2M as of Mar 2015.